Knight Therapeutics is thrilled to lead a team in the 2018 Ride to Conquer Cancer®, benefiting the Segal Cancer Centre at the Jewish General Hospital.
Last year, Knight Therapeutics had 20 riders and raised over $100,000 for cancer research – a disease that touches 1 in 3 Canadians. This year, Team Knight is teaming up with McGill’s Desautels Faculty of Management with the goals of fielding the largest team in Quebec and more than doubling last year’s fundraising total.
Jonathan Ross Goodman (BA’89, MBA/LLB’93) is the CEO of Montreal-based pharmaceutical company Knight Therapeutics and a Desautels Global Expert. He is also a textbook case of how to overcome adversity: A 2011 biking accident left him in a coma for weeks and caused massive brain damage. Even today, his short-term memory is poor and he has trouble eating. But Mr. Goodman is also still a CEO and a leader in the pharma trade.
Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, today announced that Samira Sakhia, former CFO of Paladin Labs Inc. ("Paladin"), will be joining the Knight team as President and member of the Board of Directors. In her new role, beginning on August 31, 2016, Samira will report to Jonathan Ross Goodman, CEO of Knight.
The fourth annual JEDx began with a giant cocktail party as 770 people – mostly young professionals in their early 30s or younger – mingled and fressed in the lobby of the St Lawrence Centre for the Arts in Toronto.
...Jonathan Ross Goodman, president and CEO of the Montreal-based Knight Therapeutics Inc., spoke about overcoming catastrophic health hurdles.
As a university student, he became a cancer survivor, and then he went on to get a law degree and an MBA from McGill University.
On Aug. 17, 2011, everything changed for Jonathan Goodman (MBA'94).
The aggressive, hard-driving executive - at the time the CEO of hugely successful drug distributor Paladin Labs Inc. - had just sealed one of Paladin's biggest acquisitions. Taking a celebratory bicycle ride with fellow employees in the hills north of Montreal, he fell off his bike and hit his head. Despite wearing a helmet, the result was a serious brain injury.
Entrepreneurs Jonathan Goodman (MBA'94) and Mark Beaudet built Paladin Labs Inc. from zero into a $3.2-billion international pharmaceuticals distributor in only 19 years.
Now Goodman, chairman of Paladin Labs when it was sold to Pennsylvania-based Endo Health Solutions Inc. on Feb. 28, has founded Knight Therapeutics Inc. in Montreal.
In August, 2011, Paladin Labs Inc. founder and CEO Jonathan Goodman (MBA'94) was involved in a terrible bicycle accident and had to relinquish his job to recover. His position running the Montreal-based drug distributor was taken over by long-time colleague, vice-president Mark Beaudet (BCom’90), who has now been interim CEO for almost a year-and-a-half. Mr.
